Brief: Neurovive Pharmaceutical AB Q3 Pre-Tax Loss Sek 15 Million Versus Loss Sek 13.2 Million Year Ago

Abliva AB

22/11/2018 07:34

NeuroVive Pharmaceutical AB  NVP.ST :
    * Q3 PRE-TAX LOSS SEK 15 MILLION VERSUS LOSS SEK 13.2
MILLION YEAR
AGO

Source text for Eikon:  ID:nWkr6JZcTL 
Further company coverage:  NVP.ST